Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

benzinga.com/trading-ideas/movers/25/05/45692578/regeneron-sanofi-stock-falls-after-uneven-smokers-lung-drug-data

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) on Friday announced results from two Phase 3 trials of itepekimab in chronic obstructive pulmonary disease (COPD) patients.
Phase 3 AERIFY-1 trial evaluating itepekimab in adults who were former smokers with…

This story appeared on benzinga.com, 2025-05-30 12:30:47.
The Entire Business World on a Single Page. Free to Use →